Obesity I: Overview and molecular and biochemical mechanisms

RH Lustig, D Collier, C Kassotis, TA Roepke… - Biochemical …, 2022 - Elsevier
Obesity is a chronic, relapsing condition characterized by excess body fat. Its prevalence
has increased globally since the 1970s, and the number of obese and overweight people is …

[HTML][HTML] Interactions between sleep, stress, and metabolism: From physiological to pathological conditions

C Hirotsu, S Tufik, ML Andersen - Sleep science, 2015 - Elsevier
Poor sleep quality due to sleep disorders and sleep loss is highly prevalent in the modern
society. Underlying mechanisms show that stress is involved in the relationship between …

11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action

K Chapman, M Holmes, J Seckl - Physiological reviews, 2013 - journals.physiology.org
Glucocorticoid action on target tissues is determined by the density of “nuclear” receptors
and intracellular metabolism by the two isozymes of 11β-hydroxysteroid dehydrogenase …

[HTML][HTML] Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity

MJ Lee, P Pramyothin, K Karastergiou… - Biochimica et Biophysica …, 2014 - Elsevier
Central obesity is associated with insulin resistance and dyslipidemia. Thus, the
mechanisms that control fat distribution and its impact on systemic metabolism have …

The human obesity gene map: the 2005 update

T Rankinen, A Zuberi, YC Chagnon, SJ Weisnagel… - …, 2006 - Wiley Online Library
This paper presents the 12th update of the human obesity gene map, which incorporates
published results up to the end of October 2005. Evidence from single‐gene mutation …

Endocrine disrupters as obesogens

F Grün, B Blumberg - Molecular and cellular endocrinology, 2009 - Elsevier
The recent dramatic rise in obesity rates is an alarming global health trend that consumes an
ever increasing portion of health care budgets in Western countries. The root cause of …

Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism

WL Holland, SA Summers - Endocrine reviews, 2008 - academic.oup.com
Obesity and dyslipidemia are risk factors for metabolic disorders including diabetes and
cardiovascular disease. Sphingolipids such as ceramide and glucosylceramides, while …

Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?

DH Van Raalte, DM Ouwens… - European journal of …, 2009 - Wiley Online Library
At pharmacological concentrations, glucocorticoids (GCs) display potent anti‐inflammatory
effects, and are therefore frequently prescribed by physicians to treat a wide variety of …

Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease

M Bose, B Oliván, B Laferrère - Current Opinion in Endocrinology …, 2009 - journals.lww.com
The present review provides evidence for the relationship between chronic stress,
alterations in HPA activity, and obesity. Understanding these associations and its …

Metabolic comorbidities in Cushing's syndrome

F Ferrau, M Korbonits - European Journal of Endocrinology, 2015 - academic.oup.com
Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …